The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 5 of 5
PrEP Product Awareness, Preferences, and Past Experiences among Transgender Women and Men Who Have Sex with Men in Asia and Australia: The PrEP APPEAL Study
This report provides an overview of PrEP Product Awareness, Preferences, and Past Experiences among Transgender Women and Men Who Have Sex with Men in Asia and Australia (PrEP APPEAL), a survey study in 16 countries and territories in Asia and Australia. The overall goal of PrEP APPEAL was to identify values and preferences about PrEP,…
Demand Creation/Marketing, Research, Service Delivery
National HIV Strategic Plan, 2021-2026
With the aim of supporting the global community end the AIDS epidemic by 2030, this National Plan paves the way for Nepal to achieve 95-95-95 by 2026.
Asia Region ROP, 2022
The goal of 2022 Regional Operational Plan for the Asia Region is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the countries under PEPFAR in the Asia Region achieve 95-95-95, and spotlighting HIV prevention and treatment access for…
Nepal National HIV Strategic Plan, 2016-21
Nepal HIVision 202 is Nepal’s Fast-Track approach to closing the gap between people who have had services and people being left behind, by urgently and fully funding and front-loading investments to prevent new HIV infections and save lives.
National HIV Testing and Treatment Guidelines, 2020
Nepal’s National HIV Testing Guidelines of 2020 summarize the state of HIV testing, treatment in adults and adolescents, monitoring of people on anti-retroviral treatment (ART), management of HIV in children, adherence and retention, management of advanced disease, coinfections, and comorbidities, and elimination of vertical HIV transmission.